JP2024544746A5 - - Google Patents
Info
- Publication number
- JP2024544746A5 JP2024544746A5 JP2024523408A JP2024523408A JP2024544746A5 JP 2024544746 A5 JP2024544746 A5 JP 2024544746A5 JP 2024523408 A JP2024523408 A JP 2024523408A JP 2024523408 A JP2024523408 A JP 2024523408A JP 2024544746 A5 JP2024544746 A5 JP 2024544746A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- hematopoietic
- inhibitor
- population
- hematopoietic stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2114972.9 | 2021-10-19 | ||
| GBGB2114972.9A GB202114972D0 (en) | 2021-10-19 | 2021-10-19 | Gene therapy |
| PCT/EP2022/078295 WO2023066735A1 (en) | 2021-10-19 | 2022-10-11 | Gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544746A JP2024544746A (ja) | 2024-12-04 |
| JP2024544746A5 true JP2024544746A5 (https=) | 2025-10-20 |
Family
ID=78718495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523408A Pending JP2024544746A (ja) | 2021-10-19 | 2022-10-11 | 遺伝子治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240408145A1 (https=) |
| EP (1) | EP4419543A1 (https=) |
| JP (1) | JP2024544746A (https=) |
| CA (1) | CA3235572A1 (https=) |
| GB (1) | GB202114972D0 (https=) |
| WO (1) | WO2023066735A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202208550D0 (en) * | 2022-06-10 | 2022-07-27 | Ospedale San Raffaele Srl | Cyclosporin h and uses thereof |
| KR20250075694A (ko) * | 2022-09-28 | 2025-05-28 | 리제너론 파마슈티칼스 인코포레이티드 | 세포 기반 요법을 강화하기 위한 항체 저항성 변형 수용체 |
| EP4602153A1 (en) | 2022-10-11 | 2025-08-20 | Fondazione Telethon ETS | 3d cell culture methods |
| EP4534654A1 (en) * | 2023-10-02 | 2025-04-09 | Consorcio Centro de Investigación Biomédica en Red | Pre-stimulation method of cd34+ cells to achieve clinically relevant gene editing frequencies |
| WO2025083700A1 (en) * | 2023-10-20 | 2025-04-24 | Indian Institute Of Science Education And Research, Bhopal | A small molecule formulation (transducemax) for maximal gene delivery by lentiviral transduction and method of preparation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5723315A (en) | 1996-08-23 | 1998-03-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| WO1998005635A1 (en) | 1996-08-07 | 1998-02-12 | Darwin Discovery Limited | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| PT904392E (pt) | 1996-10-17 | 2001-06-29 | Oxford Biomedica Ltd | Vectores retrovirais |
| CA2986310A1 (en) * | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| EP3368052B1 (en) * | 2015-10-27 | 2021-12-08 | Children's Hospital Medical Center | Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and genetic manipulation |
| AU2017312132A1 (en) * | 2016-08-19 | 2019-03-21 | Bluebird Bio, Inc. | Genome editing enhancers |
| EP3574088A4 (en) * | 2017-01-27 | 2020-09-23 | Children's Hospital Medical Center | PROCESSES FOR IMPROVING HEMATOPOIETIC STEM CELL TRANSPLANT ACTIVITY |
| AU2019294294A1 (en) | 2018-06-25 | 2021-02-11 | Fondazione Telethon Ets | Gene therapy |
-
2021
- 2021-10-19 GB GBGB2114972.9A patent/GB202114972D0/en not_active Ceased
-
2022
- 2022-10-11 WO PCT/EP2022/078295 patent/WO2023066735A1/en not_active Ceased
- 2022-10-11 US US18/702,592 patent/US20240408145A1/en active Pending
- 2022-10-11 EP EP22802559.9A patent/EP4419543A1/en active Pending
- 2022-10-11 JP JP2024523408A patent/JP2024544746A/ja active Pending
- 2022-10-11 CA CA3235572A patent/CA3235572A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024544746A5 (https=) | ||
| Aghajani Nargesi et al. | Mesenchymal stem cell-derived extracellular vesicles for renal repair | |
| Mirkovitch et al. | Scaffold attachment of DNA loops in metaphase chromosomes | |
| JP2022180510A (ja) | 胎児ヘモグロビンの発現を増加させる方法 | |
| de Mendonca et al. | Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension | |
| Wu et al. | Precise let-7 expression levels balance organ regeneration against tumor suppression | |
| JP2020124212A5 (https=) | ||
| CN106536719B (zh) | 来自多名骨髓供体的合并的单核细胞的间充质基质细胞库的产生 | |
| Xu et al. | Therapeutic application of endothelial progenitor cells for treatment of cardiovascular diseases | |
| CN110982776B (zh) | 肝细胞的体外扩增培养方法及应用 | |
| Tomaz et al. | Generation of functional hepatocytes by forward programming with nuclear receptors | |
| US20190048339A1 (en) | Methods for reactivating genes on the inactive x chromosome | |
| Kim et al. | Enhanced angiogenic activity of dimethyloxalylglycine-treated canine adipose tissue-derived mesenchymal stem cells | |
| Greene et al. | Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection | |
| EP0800575B1 (fr) | Procede de transfert de gene dans des cellules activees a partir d'un etat de repos | |
| Lou et al. | Heterogeneity and plasticity of cholangiocytes in liver injury: a journey from pathophysiology to therapeutic utility | |
| EP3964579A1 (en) | Method for predicting effectiveness of treatment of hemoglobinopathy | |
| Pesce et al. | Endothelial and cardiac progenitors: boosting, conditioning and (re) programming for cardiovascular repair | |
| JP2005521632A5 (https=) | ||
| EP3747993A1 (en) | Method for producing cardiomyocytes | |
| CN103898050A (zh) | 高效分泌一氧化氮的重组间充质干细胞及其制备方法与应用 | |
| CN101368180A (zh) | 一类能将间充质干细胞分化为造血细胞的小rna分子及其作用靶点 | |
| Ouyang et al. | Dynamic analysis of intrahepatic T cells reveals a unique group of restorative Cxcr3+ tissue-resident CD4 T cells in acute liver injury | |
| JP7409670B2 (ja) | 多能性幹細胞を除去するための組成物、及び多能性幹細胞の除去方法 | |
| JP2025502150A5 (https=) |